|Day Low/High||203.20 / 208.00|
|52 Wk Low/High||150.37 / 228.91|
And why I won't recommend any other stocks in these markets, right now.
In our constant evaluation of the market, we have identified these stocks to be removed from our bullpen.
If you are looking to invest in the fast-growing pot sector, this Canadian cannabis startup has been in early on the action.
Searching Beyond Canopy Growth, Tilray and Cronos reveals a plethora of investment options with companies such as Valens GroWorks and others.
Right now they are speculative growth stocks through and through.
U.S. stock futures are higher amid progress in trade negotiations between the U.S. and China; Nvidia jumps after the chipmaker forecasts a rebound in gaming chip demand; revenue at cannabis company Canopy Growth soars; PepsiCo reports earnings.
Canopy Growth posts better-than-expected fiscal third-quarter revenue and says its chief financial officer plans to depart the company later this year.
Jim Cramer explains why the cannabis industry will end up being so disruptive to the beer industry.
Aurora Cannabis reported Monday night. Here's what we think.
Jim Cramer takes a closer look at Jeff Bezos, Amazon and your game plan for the end of earnings season.
Jim Cramer takes a closer look at Home Depot, U.S. Concrete, Marathon Petroleum, Constellation Brands, Alexion Pharmaceuticals and more.
Talk about three very different headlines. Here's what you're missing on TheStreet.
Like the Rams' whiz kid head coach, these upstart stocks have a bright future.
Eight of these 11 trade ideas are in the green, with a few big winners.
While consolidation may be key to the cannabis market in 2019, this IPO is worthy of a deeper dive.
CBD could make coffee an around the clock craze.
The bid Sears just received is astoundingly huge.
Jim Cramer talks about how this market is taking its cues from the positives, and shrugging off the negatives.
CPG companies could be the keys to cannabis' continued growth.
Tilray shares fall after the expiration of the lock on the shares that prevented investors from selling holdings from the company's July public listing.
Canadian pot producer gets license to grow and distribute hemp in New York state.
Real Money's Kevin Curran takes a look at which company could be the Google of cannabis.
Stephen Guilfoyle, a contributor for Real Money, breaks down the retail and cannabis sectors.
The retail sector, Constellation and bank earnings are three things you need to know on TheStreet.
Constellation Brands lrebounds after weaker-than-expected quarterly earnings and a muted outlook pegged to rising costs associated with its $4 billion investment in cannabis specialists Canopy Growth sent its shares to a two-year low.
Canopy Growth's smoking engine won't necessarily ensure smooth sailing for Constellation.
Analysts have noted that the weed leader's momentum is set to burn higher moving forward.
I'm strategizing a risk reversal here using a put sale to fund a long-side play.
Even formerly bearish analysts are changing their tune as the risks appear to be fully baked in at this point.
A number of analysts maintain the beer and wine giant's valuation is even more attractive for long-term investors thanks to a sharp decline in its shares.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.